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1. Introduction 
Increasing evidence indicates that the divalent 
cation Ca”and the cyclic nucleotides act as central 
regulatory signals for numerous events in animal cells 
(for review, see [l-3] ). In vertebrate muscle, Ca2+ 
regulates actomyosin activity primarily through its 
action on the calcium binding component of the 
troponin complex, troponin C. Recently, a ubiquitous 
troponin C-like protein with high affinity for Ca2’ has 
been shown to be present in relatively high levels as a 
soluble component in neurosecretory tissue of numerous 
vertebrate species [4] and in rapidly proliferating 
frbroblasts [5,6]. This protein, referred to as modulator 
protein*, is structurally similar to vertebrate muscle 
troponin C [7], and has previously been shown to 
possess two potential regulatory functions in animal 
cells. First, in the presence of calcium this protein will 
stimulate the activity of partially purified preparations 
of cyclic nucleotide phosphodiesterase as first shown 
by Cheung [8] and Kakiuchi [9]. Second, Cheung and 
co-workers [ IO,1 1 ] and others [ 121 have shown that 
modulator protein is also a calcium-dependent 
stimulator of partially purified preparations of Lubrol 
solubilized adenyl cyclase activity. We report here 
that modulator protein possesses troponin C-like 
activity in Ca2+-regulated actomyosin systems from 
skeletal muscle. In the presence of troponin I and 
tropomyosin from skeleta muscle it is as effective in 
*Because of its potential multiple regulatory functions, the 
protein has previously been termed a modulator protein [ 7 I. 
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restoring Ca”-sensitivity to desensitized actomyosin 
as is the whole troponin complex and tropomyosin, 
both isolated from skeletal muscle. 
2. Methods 
2.1. Muscle proteins 
Troponin from white skeletal muscle of the rabbit 
was prepared by the method of Ebashi et al. [ 131 
and further purified by chromatography on DEAE- 
cellulose in 50 mM Tris-HCl, 15 mM 2-mercapto- 
ethanol, pH 8.0 [ 141. Troponin C and troponin T 
were prepared by chromatography of troponin on 
DEAE-Cellulose in 8.0 M urea 50 mM Tris-HCl, 
15 mM 2-mercaptoethanol, pH 8.0 [ 151. Troponin I 
was purified from troponin B by chromatography on 
CM-Cellulose in 8.0 M urea, 50 mM sodium formate, 
15 mM 2-mercaptoethanol, pH 4.0 [ 161. Tropomyosin 
and desensitized actomyosin were prepared from 
white skeletal muscle of the rabbit as described by 
Cummins and Perry [ 171. The purity of all protein 
preparations was checked before use by polyacrylamide 
gel electrophoresis in sodium dodecyl sulphate at 
pH 7.0 [18]. 
2.2. Brain modulator protein 
Bovine brain modulator protein was prepared and 
tested for purity (greater than 95%) as described by 
Watterson et al. [7]. This preparation was identical 
in phosphodiesterase activator activity, physico- 
chemical properties, and in primary structure so far as 
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Volume 72, number 1 FEBSLETTERS December 1976 
could be judged from tryptic peptide maps with the 
phosphodiesterase activator protein from bovine heart 
[ 191 prepared by a different procedure [20] . 
2.3. Enzymic assays 
These were carried out in general as described by 
Schaub and Perry [21]. Specific details are described 
in the figure legends. 
3. Results 
Brain modulator protein behaved in a very similar 
manner to troponin C from white skeletal muscle in 
relieving the inhibition by white skeletal muscle 
troponin I of the Mg*‘-stimulated ATPase of desensitiz- 
ed actomyosin in the absence EGTA (fig. 1). In both 
cases neutralisation of the inhibition was complete 
when the molar ratio of troponin C or modulator 
protein to troponin I was about 0.5 [22]. 
In the presence of EGTA, brain modulator protein 
Mole TROPONIN C Mole MOQULATOR PROTEIN 
Mole TROPONIN I Mole TROPONIN I 
Fig.1. The effects of bovine brain modulator protein and 
rabbit skeletal muscle troponin C on the inhibition of the 
Mg’+-stimulated ATPase of desensitized actomyosin by rabbit 
skeletal troponin I. ATPase assays carried out in 25 mM 
Tris-HCl, pH 7.6, 2.5 mM ATP 2.5 mM MgCl, with 450 pg 
desensitized actomyosin and 150 pg tropomyosin and in the 
presence or absence of 1 mM EGTA as indicated. Total volume 
2 ml, incubated 5 min at 25°C. Activities expressed as 
percentage of that obtained in the absence of troponin I. (a) 
Effect of increasing amounts of troponin C from rabbit white 
skeletal muscle. (0) EGTA absent, (0) 1 mM EGTA. (b) Effect 
of increasing amounts of bovine brain modulator protein. 
(0) EGTA absent, (0) 1 mM EGTA. 
differed quantitatively from troponin C from white 
skeletal muscle in that it was completely ineffective 
in relieving the inhibition of ATPase activity by 
troponin I, i.e., the mixture of muscle troponin I and 
brain modulator protein restored Ca*‘-sensitivity to 
the muscle actomyosin ATPase. At lower molar ratios 
of skeletal troponin C to troponin I, some Ca*+-sensi- 
tivity of the ATPase was observed [22] , although it 
was not complete and disappeared at higher ratios 
(fig. la). Calcium sensitivity was restored to the system 
at all ratios of modulator protein to troponin I tested 
(flg.lb). Brain modulator protein alone or in the 
presence of troponin T had no effect on the Mg*‘- 
stimulated ATPase activity of desensitized actomyosin 
to which tropomyosin had been added, either in the 
presence of absence of 1 mM EGTA. No Ca**-sensitivity 
was obtained with any combination of the regulatory 
proteins in the absence of tropomyosin. 
When ATPase activities were compared at equal 
troponin I concentrations in the presence of tropo- 
myosin, a mixture containing skeletal troponin I and 
brain modulator protein in the molar ratio of 1.0 : 0.5 
was just as effective in restoring Ca*+-sensitivity to the 
Mg*‘-stimulated ATPase as was the whole troponin 
complex from skeletal muscle containing troponin I, 
troponin C and troponin T in the molar ratio 1 : 1 : 1. 
The above experiments would not reveal any 
differences in response at different Ca*+ concentrations 
as they were carried out in the presence of 1 mM 
EGTA which effectively reduced the Ca*+ concentra- 
tion to less than 10e8 M. When the ATPase activity of 
the reconstituted actomyosin systems were assayed 
over a range of Ca*+ concentrations fixed by the use 
of a Ca buffer system [23] however, the troponin 
regulated system was 50% activated at a slightly 
lower Ca” concentration (about 0.5 ,&a*’ unit) than 
that required to produce similar activation with the 
equimolar mixture of brain modulator protein and 
muscle troponin I (flg.2). As the Mg*‘-stimulated 
ATPase of desensitized actomyosin is very sensitive 
to ionic strength, enzymic assays were carried out at 
low ionic strength. Under these conditions maximal 
activation of myofibrillar and actomyosin ATPase 
occurs at pCa*’ values of about 7 [24] . 
A possible explanation of the difference in their 
abilities of modulator protein and troponin C to 
restore Ca*‘-sensitivity to the actomyosin ATPase 
was that the skeletal troponin C was slightly modified 
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although usually only a single additional band is seen 
20 when it is complexed with white skeletal troponin I. 
In the presence of Ca2+ the electrophoretic mobility 
of modulator protein at pH 8.0 is slightly reduced as 
-LOG [cd+1 would be expected from the decrease in negative charge 
on the protein resulting from binding the cation. 
Fig.2. The effects of Ca* concentration on the ATPase activity Skeletal muscle troponin C increases in mobility under 
of desensitized actomyosin in the presence of skeletal muscle similar conditions for the decrease in hydrated volume 
troponin and an equimolar mixture of brain modulator 
protein and white skeletal muscle troponin 1. Assay conditions 
associated with the conformational change that occurs 
generally as indicated for fig.1. Ca*-EGTA buffers were made 
when calcium ions are bound more than compensates 
as described by Charbarek and Martell [ 231. (0) Troponin for the charge effect [27]. 
complex from white skeletal muscle of the rabbit, (0) equi- Evidence was also obtained from the electrophoretic 
molar mixture of bovine brain modulator protein and white studies for the formation of a brain modulator protein- 
skeletal troponin 1. skeletal troponin T complex (iig.3g) using conditions 
analogous to those under which the skeletal troponin 
C-skeletal troponin T complex can be demonstrated 
by the procedures used in its preparation. This involves [28]. In the presence of EGTA the band corresponding 
exposure to high concentrations of urea whereas brain to the complex disappeared completely (fig.3h). No 
modulator protein, which is obtained by very mild evidence was obtained from the electrophoretic studies 
conditions, should have retained all the properties of for direct interaction between brain modulator protein 
the native protein. This was not the explanation, for and tropomyosin. If however, skeletal troponin T was 
after incubation for 12 h at 20°C in 8.0 M urea, present interaction between tropomyosin and the brain 
50 mM Tris-HCl, pH 7.6, and subsequent removal modulator protein-skeletal troponin T complex could 
of the urea by dialysis against water, the ability of be demonstrated (fig.3k). 
modulator protein to restore Ca”-sensitivity with 
skeletal troponin I was no different from that of 
untreated preparations of the protein. 4. Discussion 
All other samples of muscle troponin C tested, 
including those prepared from bovine heart and The evidence from studies of the physical properties 
chicken breast, as well as the rabbit skeletal muscle and amino acid sequence indicating that the brain 
protein modified by nitration [25] and carboxymethyla- modulator protein is similar to troponin C from 
tion [26] were unable to restore complete Ca2’-sensiti- skeletal muscle is further strengthened by the finding 
vity to the actomyosin ATPase activity in the presence that it also possesses a number of the biological 
of added troponin I and tropomyosin. properties of muscle troponin C. These include the 
On polyacrylamide gel electrophoresis at pH 8.6, ability to neutralise the inhibitory activity of 
brain modulator protein migrated rapidly to the anode troponin I from skeletal muscle and to form Ca’+- 
with a mobility slightly less than that of troponin C dependent complexes with troponin T and I, the latter 
from white skeletal muscle (fig.3a). In the presence of being stable to high urea concentration. As troponin T 
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Ca”, a complex was formed with equimolar amounts 
of skeletal troponin I with a mobility of about 50% 
of that of the brain modulator protein. The complex 
was not formed in the absence of Ca”. It was similar 
to that formed by skeletal troponin C and troponin I 
[27] in its electrophoretic mobility and stability in 
6.0 M urea in the presence of Ca”. With some prepara- 
tions of skeletal troponin I, brain modulator protein 
formed several bands of complex (fig.3d). This pheno- 
menon also is observed with skeletal troponin C 
165 
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Fig.3. Electrophoresis of bovine brain modulator protein and the components of regulatory protein complex from rabbit skeletal 
muscle. Final conditions: 10% polyacrylamide, 25 mM Tris-80 mM glycine, pH 8.6 [ 181. Gels stained in 0.25% Coomassie Brilliant 
Blue R in 50% (w/v) trichloroacetic acid and destained in methanol/acetic acid/water (5: 1: 14, by vol.) (o) Origin. (a) 15 pg brain 
modulator protein, (b) 15 pg skeletal muscle troponin C, (c) 10 fig skeletal troponin C + 5 pg skeletal troponin I, (d) 10 ng brain 
modulator protein + 5 I.rg skeletal troponin I, (e) 10 Mug brain modulator protein + 5 pg skeletal troponin I + 2 mM EGTA, (f) 10 pg 
skeletal troponin C + 10 Mg skeletal troponin T, (g) 10 pg brain modulator protein + 10 fig skeletal troponin T, (h) 10 pg brain 
modulator protein + 10 pg skeletal troponin T + 2 mM EGTA, (i) 40 pg skeletal tropomyosin, (i) 10 pg brain modulator protein + 
10 pg skeletal tropomyosin (k) 10 pg brain modulator protein + 10 Mg skeletal troponin T + 40 Mg skeletal tropomyosin. 
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is considered to be the component that binds the 
troponin complex to specific sites on tropomyosin of 
the I filament of the muscle, the interaction between 
troponin T and troponin C is presumably the link 
involved in the process. Nevertheless, although the 
brain modulator protein possesses the property of 
interacting with skeletal troponin T, troponin T is not 
essential for the restoration of Ca2+-sensitivity to the 
Mg”-stimulated ATPase of muscle actomyosin by brain 
modulator protein in the presence of muscle troponin I 
and tropomyosin. 
The electrophoretic evidence suggests that neither 
troponin I nor brain modulator protein interact with 
tropomyosin. This implies that the troponin I-brain 
modulator protein complex need to be directly linked 
to tropomyosin for Ca2+-regulation of the actomyosin 
ATPase in the system described. In the light of these 
facts and the observation that under certain conditions 
troponin T likewise is not required for Ca2+-sensitivity 
of the ATPase skeletal actomyosin systems [22], the 
role of troponin T and of tropomyosin in the regulation 
of myofibrillar actomyosin ATPase activity requires 
re-examination. The results obtained with brain 
modulator protein are not easily reconciled with 
models involving troponin C linked to tropomyosin via 
troponin T and the blocking of sites on actin by the 
movement of the tropomyosin filament in the groove 
of the I filament [ 29-3 1 ] . Possibly troponin T has 
evolved as an additional regulatory protein for the 
highly developed fast-reacting control systems required 
for specialised muscle tissue. 
The troponin C-like modulator protein is widely 
distributed in both vertebrate and invertebrate species 
[4,32,33]. It should be noted that only the bovine 
brain protein was tested in the present study. However, 
the physico-chemical properties, phosphodiesterase 
activator activities and tryptic peptide maps of the 
modulator proteins prepared from bovine, porcine, 
rabbit, rat and chicken brains are virtually identical 
[34]. These proteins would therefore, be expected to 
have very similar abilities to interact with the muscle 
actomyosin system used in the present study. 
The relationship of the brain modulator protein to 
the troponin C-like protein isolated from brain by 
Fine et al. [35] is not clear. The two proteins show 
many similarities although, unlike the modulator 
protein, the troponin C-like protein of Fine et al. [35] 
apparently required troponin T for restoration of 
calcium sensitivity to skeletal actomyosin ATPase. 
In addition to their highly conserved structural and 
functional properties, all modulator proteins tested 
to date contain a specifically trimethylated lysine 
residue. The role of this specific modification is unclear 
at present. However, rabbit skeletal muscle troponin C 
which lacks this methylated amino acid does not 
activate cyclic nucleotide phosphodiesterase [36] 
despite its structural similarity to modulator protein. 
It can be concluded that troponin C-like modulator 
proteins present in many tissues may have a multi- 
functional role, controlling contractile activity as well 
as the metabolism of 3’,5’-cyclic adenylic acid. When 
tested with actomyosin and regulatory proteins derived 
from muscle, these troponin C-like proteins isolated 
from non-muscle tissue can provide valuable insight 
into the mechanism of action of the actomyosin regu- 
latory protein system. 
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